Copeptin antibody and antigen (Recombinant protein)
Diagnostic Copeptin antibodies (anti-Copeptin, anti-Copeptin) and antigens (recombinant Copeptin protein) for Diabetes diseases Copeptin detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-h-Copeptin-Ag01 | Recombinant human AVP/Copeptin/ARVP/VP Protein | 3090 |
GMP-h-Copeptin-Ab01 | Anti-human AVP/Copeptin/ARVP/VP mouse monoclonal antibody (mAb) | 1953 |
GMP-h-Copeptin-Ab02 | Anti-human AVP/Copeptin/ARVP/VP mouse monoclonal antibody (mAb) | 1953 |
GMP-h-Copeptin-Ab03 | Anti-human AVP/Copeptin/ARVP/VP human monoclonal antibody (mAb) | 1953 |
GMP-h-Copeptin-Ab04 | Anti-human AVP/Copeptin/ARVP/VP human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-h-Copeptin-Ag01 |
Product Name | Recombinant human AVP/Copeptin/ARVP/VP Protein |
Target/Biomarker | Copeptin (Copeptin) |
Alias of Target/Biomarker | ADH, ARVP, AVP-NPII, AVRP, VP |
Expression platform | mammalian |
Isotypes | Recombinant Antigen |
Bioactivity validation | Copeptin (Copeptin) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Copeptin level test of Diabetes diseases (diabetes insipidus, syndrome of inappropriate antidiuresis (SIAD)) and related syndrome evaluation. |
Tag | His |
Products description | Recombinant human AVP/Copeptin/ARVP/VP Protein was expressed in mammalian expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-h-Copeptin-Ab01, GMP-h-Copeptin-Ab02 |
Product Name | Anti-human AVP/Copeptin/ARVP/VP mouse monoclonal antibody (mAb) |
Target/Biomarker | Copeptin (Copeptin) |
Alias of Target/Biomarker | ADH, ARVP, AVP-NPII, AVRP, VP |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Copeptin (Copeptin) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Copeptin level test of Diabetes diseases (diabetes insipidus, syndrome of inappropriate antidiuresis (SIAD)) and related syndrome evaluation. |
Tag | mFc |
Products description | Anti-human AVP/Copeptin/ARVP/VP mouse monoclonal antibody (mAb) was expressed in CHO expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-h-Copeptin-Ab03, GMP-h-Copeptin-Ab04 |
Product Name | Anti-human AVP/Copeptin/ARVP/VP human monoclonal antibody (mAb) |
Target/Biomarker | Copeptin (Copeptin) |
Alias of Target/Biomarker | ADH, ARVP, AVP-NPII, AVRP, VP |
Expression platform | CHO |
Isotypes | Human lgG1 |
Bioactivity validation | Copeptin (Copeptin) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Copeptin level test of Diabetes diseases (diabetes insipidus, syndrome of inappropriate antidiuresis (SIAD)) and related syndrome evaluation. |
Tag | hFc |
Products description | Anti-human AVP/Copeptin/ARVP/VP human monoclonal antibody (mAb) was expressed in CHO expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Copeptin is secreted in an equimolar amount to arginine vasopressin (AVP) but can easily be measured in plasma or serum using immunodiagnosis. Copeptin has been used as diagnostic biomarker in vasopressin‐dependent disorders of body fluid homeostasis such as hyper‐ and hypoosmolar circumstances. The hyperosmolar disorder is diabetes insipidus, while the hypoosmolar disorder is the syndrome of inappropriate antidiuresis (SIAD).
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments